Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DNA XSONM +4.50%40 EV-to-EBITDA is -0.61 as of Jul. 30, 2026. GuruFocus rates SONM with a GF Score™ of 40/100 and a GF Value™ of $29.79 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,959 Software companies, DNA X ranks worse than 51046.4% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, DNA X's enterprise value is $4.72 Mil.
DNA X's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-7.70 Mil. Therefore, DNA X's EV-to-EBITDA for today is -0.61.
The historical rank and industry rank for DNA X's EV-to-EBITDA or its related term are showing as below:
SONM'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -96.2 Med: -0.22 Max: 181.59
Current: -0.61
During the past 9 years, the highest EV-to-EBITDA of DNA X was 181.59. The lowest was -96.20. And the median was -0.22.
SONM's EV-to-EBITDA is ranked worse than 100% of 1959
companies
in the Software industry
Industry Median: 10.4
vs SONM: -0.61
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2026-07-30), DNA X's stock price is $3.26.
DNA X's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-23.480. Therefore, DNA X's PE Ratio (TTM) for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
DNA X (NAS:SONM) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
DNA X's share price for today is $3.26.
DNA X's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.480.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for DNA X's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Infrastructure subindustry, DNA X's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DNA X EV-to-EBITDA vs Software Industry
For the Software industry and Technology sector, DNA X's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where DNA X's EV-to-EBITDA falls into.
DNA X's current Enterprise Value is $4.72 Mil.
DNA X's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DNA X (SONM) has a EV-to-EBITDA of -0.61 as of Jul. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on DNA X. According to the industry distribution chart, DNA X ranks #999999 out of 1959 companies in the Software industry.
Is DNA X's EV-to-EBITDA too high?
DNA X's current EV-to-EBITDA is -0.61. Based on the distribution chart, DNA X ranks #999999 out of 1959 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, DNA X has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does DNA X's EV-to-EBITDA compare to CETX and OLB?
According to the Software industry distribution chart, DNA X ranks #999999 out of 1959 companies for EV-to-EBITDA. This places DNA X in the lower half of its industry. The industry median EV-to-EBITDA is 10.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Software company?
The median EV-to-EBITDA among Software companies is 10.40, based on 1,959 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on DNA X. For the Software industry, the median EV-to-EBITDA is 10.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DNA X's current EV-to-EBITDA is -0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DNA X stock overvalued right now?
Based on GuruFocus' analysis, DNA X (SONM) is currently considered Possible Value Trap. The stock's GF Value™ is $29.79, compared to a current price of $3.26 — trading 89.1% below its estimated fair value. The current EV-to-EBITDA is -0.61. DNA X's overall GF Score™ is 40/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For DNA X (SONM), the current EV-to-EBITDA is -0.61 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DNA X (SONM) Overvalued in 2026?
Based on GuruFocus' analysis, DNA X stock appears to be undervalued.
The current stock price of $3.26 is trading 89.1% below its estimated GF Value™ of $29.79.
GuruFocus considers DNA X to be Possible Value Trap.
Key valuation signals for SONM:
EV-to-EBITDA: -0.61
GF Value™: $29.79 vs. price of $3.26 (89.1% below fair value)
No single metric tells the full story. See the SONM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
40GF Score
Get the complete analysis for SONM
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SONM has been successfully added to your 
